Ibuprofeno Braun

Ibuprofen, the active ingredient in Ibuprofeno Braun, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an intravenous solution for intravenous use. It provides analgesic, antipyretic and anti‑inflammatory effects for patients requiring rapid systemic therapy, such as those with postoperative or musculoskeletal pain.

GNH USA supplies Ibuprofeno Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Clients benefit from consistent product availability, regulatory support and responsive technical service.

Ibuprofeno Braun (ibuprofen) acts on inflammatory pathways to relieve pain and fever. - Mild to moderate pain: delivers effective analgesia within minutes, helping patients manage everyday discomfort. - Fever: lowers elevated body temperature, providing antipyretic control during infectious or inflammatory states. - Inflammation: reduces prostaglandin‑mediated swelling, improving joint mobility and comfort. - Post‑operative pain: offers rapid pain control after surgery, facilitating early mobilization. - Musculoskeletal pain: eases aches from strains, sprains, and arthritic conditions. - Acute injury pain: mitigates pain associated with trauma, supporting timely clinical assessment.

Ibuprofeno Braun may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Nausea: mild stomach upset that often resolves without intervention. - Dyspepsia: discomfort or burning sensation in the upper abdomen. - Headache: transient head pain occurring during treatment. - Injection site pain: local discomfort at the IV insertion point. - Diarrhea: loose stools that are usually self‑limiting.

Serious or Rare Side Effects: - Gastrointestinal bleeding: potentially life‑threatening hemorrhage in the stomach or intestines. - Renal impairment: reduced kidney function, especially in patients with pre‑existing disease. - Severe allergic reaction: anaphylaxis presenting with rash, swelling, and respiratory distress. - Hepatotoxicity: elevated liver enzymes indicating liver injury. - Cardiovascular events: increased risk of heart attack or stroke in susceptible individuals.

Before using Ibuprofeno Braun, clinicians should consider several precautionary measures to minimize risk. - Assess renal function: evaluate baseline kidney status, especially in elderly or dehydrated patients. - Monitor gastrointestinal risk: avoid use in patients with active ulcers or a history of GI bleeding. - Review cardiovascular history: use cautiously in individuals with heart disease or hypertension. - Check for drug allergies: confirm no known hypersensitivity to ibuprofen or other NSAIDs. - Avoid concurrent anticoagulants: limit combined use with warfarin, heparin or novel oral anticoagulants unless closely monitored. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ibuprofeno Braun can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - Corticosteroids: amplified risk of stomach ulceration. - Selective serotonin reuptake inhibitors (SSRIs): elevated chance of bleeding. - ACE inhibitors or ARBs: may reduce renal function when combined.

Moderate Interactions (Monitor Closely): - Diuretics: possible decrease in antihypertensive effect. - Lithium: ibuprofen can raise lithium serum levels. - Methotrexate: reduced clearance leading to toxicity. - Cyclosporine: increased nephrotoxic potential. - Antihypertensive agents: may blunt blood pressure control.